These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3683771)

  • 1. Systemically administered cholecystokinin affects an evoked potential in the hippocampal dentate gyrus.
    Dahl D
    Neuropeptides; 1987; 10(2):165-73. PubMed ID: 3683771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central administration of cholecystokinin potentiates evoked potential amplitude in the hippocampal dentate gyrus.
    Dahl D
    Neuropeptides; 1988; 11(4):147-51. PubMed ID: 3419554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin and an evoked response in the dentate gyrus.
    Sinton CM
    Neuropeptides; 1988 Jul; 12(1):29-34. PubMed ID: 3419558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin modulates neurotransmission through the dentate gyrus.
    Sinton CM
    Neurosci Lett; 1988 Dec; 95(1-3):341-6. PubMed ID: 2852324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin and cholecystokinin antagonists enhance postsynaptic excitability in the dentate gyrus.
    Sinton CM
    Peptides; 1988; 9(5):1049-53. PubMed ID: 3244557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones.
    Bradwejn J; de Montigny C
    Nature; 1984 Nov 22-28; 312(5992):363-4. PubMed ID: 6095093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
    Wu T; Wang HL
    Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronotropic actions of cholecystokinin octapeptide on the rat heart.
    Marker JD; Roberts ML
    Regul Pept; 1988 Mar; 20(3):251-9. PubMed ID: 3363182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin (CCK-33) and its fragments, C-terminal octapeptide (CCK-8) and C-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats.
    Fiedorowicz RJ; Wiśniewski K
    Pol J Pharmacol Pharm; 1989; 41(6):561-72. PubMed ID: 2485904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cholecystokinin octapeptide sulphate ester and unsulphated cholecystokinin octapeptide on active avoidance behaviour in rats.
    Fekete M; Bokor M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(1-2):57-63. PubMed ID: 6306996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-octapeptide restored morphine-induced hippocampal long-term potentiation impairment in rats.
    Wen D; Zang G; Sun D; Yu F; Mei D; Ma C; Cong B
    Neurosci Lett; 2014 Jan; 559():76-81. PubMed ID: 24309294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-induced hypothermia in the rat.
    Katsuura G; Hirota R; Itoh S
    Experientia; 1981 Jan; 37(1):60. PubMed ID: 6258973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Britton DR; Yahiro L; Cullen MJ; Kerwin JF; Kopecka H; Nadzan AM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):779-83. PubMed ID: 2623030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro.
    Jarvis CR; Bourque CW; Renaud LP
    J Physiol; 1992 Dec; 458():621-32. PubMed ID: 1302281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
    Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
    Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cholecystokinin in ganglionic transmission in the guinea-pig gall-bladder.
    Mawe GM
    J Physiol; 1991 Aug; 439():89-102. PubMed ID: 1654421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.